SOUTH JORDAN, Utah, July 10 /PRNewswire-FirstCall/ -- Merit Medical Systems, Inc. (Nasdaq: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that sales for the second quarter ended June 30, 2008 were approximately $57.4 million, an increase of 11% over the second quarter of 2007, which the Company believes will produce earnings in the range of $0.19-$0.21 per share for the quarter. Gross margins for the second quarter are estimated to be approximately 42.7%, which would result in an increase of 500 basis points from the second quarter of 2007.
The Company cautioned that these estimates are unaudited and are subject to modification or revision in the course of completing the Company's quarter- end financial review and audit of the Company's financial results.
Full details and final results will be reported at 4:00 p.m. Eastern Time on Wednesday, July 23rd, 2008. Merit's management will hold a conference call to discuss the specifics the same day (July 23rd) at 5:00 p.m. ET. The telephone numbers to call are (domestic) 800-218-9073; and (international) 303-205-0033. A live webcast will also be available for the conference call at http://www.merit.com and http://www.fulldisclosure.com . The webcast will be archived on both sites.
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 90 individuals. Merit employs approximately 1,600 people worldwide, with facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; and Galway, Ireland.
Statements contained in this release, which are not purely historical, are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 and are subject to risks and uncertainties such as those described in Merit's Annual Report on Form 10-K for the year ended December 31, 2007. Such risks and uncertainties include product recalls and product liability claims; infringement of Merit's technology or the assertion that Merit's technology infringes the rights of other parties; termination of relationship with suppliers, or failure of suppliers to perform; inability to successfully manage growth through acquisitions; delays in obtaining regulatory approvals, or the failure to maintain such approvals; concentration of Merit's revenues among a few products and procedures; development of new products and technology that could render Merit's products obsolete, market acceptance of new products, introduction of products in a timely fashion, price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of Merit's common stock; foreign currency fluctuations; key personnel; work stoppage or transportation risks; modification or limitation of governmental or private insurance reimbursement, changes in health care markets related to health care reform initiatives; and other factors referred to in Merit's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.
|SOURCE Merit Medical Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved